Seladelpar
id:
seladelpar-182-4219468
title:
Seladelpar
text:
Seladelpar, sold under the brand name Livdelzi, is a medication used for the treatment of primary biliary cholangitis. It is used as the lysine dihydrate salt. It is a PPARδ receptor agonist. The compound was licensed from Janssen Pharmaceutica NV. Seladelpar was approved for medical use in the United States in August 2024.
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Seladelpar
date created:
2013-04-02T15:03:12Z
date modified:
2024-09-06T04:24:27Z
main entity:
{"identifier":"Q27268037","url":"https://www.wikidata.org/entity/Q27268037"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/5/50/Seladelpar.svg","width":512,"height":210}
fields total:
13
integrity:
16